BACKGROUND & OBJECTIVES
Danish Diabetes Academy (DDA) constitutes an original networking platform for a national diabetes research strategy that is rational and science-based, and which will strengthen both basic and clinical research in diabetes. DDA is expected to foster enhanced collaboration between Danish diabetes research environments and ensure rapid distribution and shared access to novel research results, ideas and technologies, thus benefiting other research groups within the organisation.
Danish Diabetes Academy (DDA) was established September 1, 2012 with a 5-year grant from the Novo Nordisk Foundation of DKK 201,880,000 (EUR 27,059,485). Danish universities and university hospitals provided co-funding totalling DKK 100,000,000.
Since its foundation, DDA has accomplished the following:
January 1, 2018, DDA received a new 5-year grant from the Novo Nordisk Foundation (NNF) of DKK 156,000,000 to support education of the next generation of diabetes researchers, as well as networking and research collaboration initiatives.